Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep324 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Diabetes, a harbinger of pancreatic tumor

Mehrzi Amal , Jemel Manel , Madhbouh Meriem , Chatti Hiba , Madhi Wiem , Kammoun Ines

IntroductionPancreatic cancer is one of the cancers of the digestive tract for which the prognosis has not been improved in terms of early diagnosis. Recent diabetes can be indicative of this pathology.ObservationA 56-year-old man with no notable pathological history who has presented for 04 months a deterioration in general condition with weight loss. On clinical examination: BMI: 17 kg/m2. In bio...

ea0073ep45 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Initial daily insuline dose and body mass index

Mehrzi Amal , yosra Htira , Bornaz Emna , Ben Hadj Ali Zohra , Mami Feyka Ben

IntroductionInsulin therapy can lead to obesity which can affect the comorbidities of the type 2 diabetes. Should we consider the body mass index (BMI) before prescribing it?MethodsOur study is prospective, randomized and comparative.We recruited patients with type 2 diabetes hospitalized for a switching to insulin in the C department of diabetology and nutrition at the National Nutrition Institute in Tunis, ...

ea0073ep107 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Initial daily insuline dose and diabetic retinopathy

Mehrzi Amal , Htira Yosra , Bornaz Emna , Zohra Ben Hadj Ali , Ben Mami Feyka

IntroductionDiabetic retinopathy is a serious complication of type 2 diabetes, which compromise the visual function and impair the quality of life of these patients. A rapid lowering of blood glucose especially when starting insulin therapy can worsen this retinopathy. We studied the variation of the initial daily insuline dose in the presence of diabetic retionopathy.MethodsOur study is prospective randomize...

ea0073ep124 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Does the initial daily insuline dose vary with the duration of diabetes ?

Mehrzi Amal , Htira Yosra , Bornaz Emna , Zohra Ben Hadj Ali , Ben Mami Feyka

IntroductionUncontrolled patients with oral antidiabetics may require injectable treatment including insulin. We studied the variation of the initial daily insuline dose with the duration of diabetes.MethodsWe conducted a prospective randomized study. We recruited patients with type 2 diabetes hospitalized for a switching to insulin in the C department of diabetology and nutrition at the National Nutrition In...

ea0081ep558 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Characteristics of dyslipidemia in a group of patients with diabetes

Mehrzi Amal , Wiem Saadi , Haifa Abdesslem , Abir El Amri , Imen Sebai , Kamilia Ouneissa , Rim Yahyaoui , Asma Ben Brahim , Chiraz Amrouche

Objective: Dyslipidemia represents an added factor of cardiovascular risk for patients with diabetes. The objective of this work was to study the characteristics of dyslipidemia in a group of patients with diabetes.Methods Cross-sectional study including a group of patients with diabetes associated with dyslipidemia, during a period of 6 months, admitted in the day hospital unit of the National Institute of Nutrition of Tunis. The data was collected by c...

ea0073ep47 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Glycemic control of patients on human insulin and those on insulin analogues, is there a difference ?

Mehrzi Amal , Abdesslem Haifa , Safi Eya , Ounaissa Kamilia , Ben Brahim Rym , Yahyaoui Rym , Sebai Imen , Amrouche Chiraz

IntroductionThe objective of our study was to compare the glycemic control between patients on human insulin and those on insulin analogues.MethodsWe conducted a prospective, randomized and comparative study. By recruiting patients with diabetes hospitalized in the day hospital departement at the National Nutrition Institute in Tunis during 8 months. The glycemic control of patients on human insulin and those...

ea0081ep530 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Degenerative complications of diabetes during the switch to insulin

Mehrzi Amal , Abir El Amri , Amani Amorri , Olfa Berriche , Faten Mahjoub , Nadia Ben Amor , Rim Ben Othmen , Ramla Mizouri , Henda Jamoussi

Introduction: Type 2 diabetes is a chronic, silent disease. Patients with diabetes could experience complications during the evolution of their disease. We studied the presence of degenerative complications during the initiation of insulin.Methods: Cross-sectional study including a group of patients with type 2 diabetes requiring a switch to insulin, hospitalized at the A department of Diabetology and Nutrition in the National Institute of Nutrition of T...